Double-edged sword of ALDH2 mutations: one polymorphism can both benefit and harm the cardiovascular system
Open Access
- 25 June 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (26), 2453-2455
- https://doi.org/10.1093/eurheartj/ehaa444
Abstract
This editorial refers to ‘Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype’†, by K. Yang et al., on page 2442.Funding Information
- NIH (R01 HL 136431, R01 HL 141917, R01 HL 147095)
This publication has 15 references indexed in Scilit:
- Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotypeEuropean Heart Journal, 2020
- miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral CancerMolecular Therapy Nucleic Acids, 2019
- Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patientsJournal of Cellular and Molecular Medicine, 2018
- Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model systemScience Translational Medicine, 2014
- Principles of miRNA-Target Regulation in Metazoan ModelsInternational Journal of Molecular Sciences, 2013
- ALDH2 Activator Inhibits Increased Myocardial Infarction Injury by Nitroglycerin ToleranceScience Translational Medicine, 2011
- Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndromeJournal of Cellular and Molecular Medicine, 2010
- Origin and dispersal of atypical aldehyde dehydrogenase ALDH2⁎487LysGene, 2009
- Thoracic and Abdominal Aortic AneurysmsCirculation, 2005
- Detection and Management of Small Aortic AneurysmsThe New England Journal of Medicine, 2002